ARRAY TECHNOLOGIES INC (ARRY)

US04271T1007 - Common Stock

6.73  -0.01 (-0.15%)

After market: 6.76 +0.03 (+0.45%)

Fundamental Rating

4

ARRY gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 88 industry peers in the Electrical Equipment industry. ARRY has an average financial health and profitability rating. ARRY has a bad growth rate and is valued cheaply.



4

1. Profitability

1.1 Basic Checks

In the past year ARRY was profitable.
ARRY had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ARRY reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: ARRY reported negative operating cash flow in multiple years.

1.2 Ratios

ARRY has a Return On Assets of -9.52%. This is comparable to the rest of the industry: ARRY outperforms 53.41% of its industry peers.
ARRY has a Return On Equity of -32.56%. This is comparable to the rest of the industry: ARRY outperforms 52.27% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.01%, ARRY is in the better half of the industry, outperforming 79.55% of the companies in the same industry.
Industry RankSector Rank
ROA -9.52%
ROE -32.56%
ROIC 7.01%
ROA(3y)-1.11%
ROA(5y)2%
ROE(3y)-11.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

In the last couple of years the Profit Margin of ARRY has declined.
With a decent Operating Margin value of 10.95%, ARRY is doing good in the industry, outperforming 77.27% of the companies in the same industry.
ARRY's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 30.91%, ARRY is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
ARRY's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.95%
PM (TTM) N/A
GM 30.91%
OM growth 3Y7.58%
OM growth 5YN/A
PM growth 3Y-7.12%
PM growth 5YN/A
GM growth 3Y4.29%
GM growth 5Y45.89%

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ARRY is destroying value.
Compared to 1 year ago, ARRY has more shares outstanding
ARRY has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ARRY has been reduced compared to a year ago.

2.2 Solvency

ARRY has an Altman-Z score of 1.60. This is a bad value and indicates that ARRY is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.60, ARRY perfoms like the industry average, outperforming 53.41% of the companies in the same industry.
The Debt to FCF ratio of ARRY is 3.77, which is a good value as it means it would take ARRY, 3.77 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.77, ARRY is in the better half of the industry, outperforming 73.86% of the companies in the same industry.
ARRY has a Debt/Equity ratio of 1.42. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.42, ARRY is not doing good in the industry: 76.14% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF 3.77
Altman-Z 1.6
ROIC/WACC0.69
WACC10.23%

2.3 Liquidity

ARRY has a Current Ratio of 2.41. This indicates that ARRY is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.41, ARRY is doing good in the industry, outperforming 65.91% of the companies in the same industry.
A Quick Ratio of 1.88 indicates that ARRY should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.88, ARRY is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.41
Quick Ratio 1.88

3

3. Growth

3.1 Past

The earnings per share for ARRY have decreased strongly by -37.56% in the last year.
The Earnings Per Share has been growing slightly by 5.44% on average over the past years.
Looking at the last year, ARRY shows a very negative growth in Revenue. The Revenue has decreased by -40.00% in the last year.
The Revenue has been growing by 40.22% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-37.56%
EPS 3Y5.44%
EPS 5YN/A
EPS Q2Q%-17.07%
Revenue 1Y (TTM)-40%
Revenue growth 3Y21.79%
Revenue growth 5Y40.22%
Sales Q2Q%-33.97%

3.2 Future

ARRY is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.23% yearly.
The Revenue is expected to decrease by -1.89% on average over the next years.
EPS Next Y-45.08%
EPS Next 2Y-15.07%
EPS Next 3Y-5.26%
EPS Next 5Y-0.23%
Revenue Next Year-41.25%
Revenue Next 2Y-14.38%
Revenue Next 3Y-6.34%
Revenue Next 5Y-1.89%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 10.52, the valuation of ARRY can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of ARRY indicates a rather cheap valuation: ARRY is cheaper than 94.32% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.41. ARRY is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 8.22 indicates a reasonable valuation of ARRY.
Based on the Price/Forward Earnings ratio, ARRY is valued cheaply inside the industry as 96.59% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.69. ARRY is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.52
Fwd PE 8.22

4.2 Price Multiples

ARRY's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ARRY is cheaper than 92.05% of the companies in the same industry.
97.73% of the companies in the same industry are more expensive than ARRY, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.7
EV/EBITDA 8.48

4.3 Compensation for Growth

ARRY's earnings are expected to decrease with -5.26% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.07%
EPS Next 3Y-5.26%

0

5. Dividend

5.1 Amount

ARRY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ARRAY TECHNOLOGIES INC

NASDAQ:ARRY (1/3/2025, 8:20:31 PM)

After market: 6.76 +0.03 (+0.45%)

6.73

-0.01 (-0.15%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners122.33%
Inst Owner Change4.09%
Ins Owners0.27%
Ins Owner Change0.69%
Market Cap1.02B
Analysts76.25
Price Target10.48 (55.72%)
Short Float %16.18%
Short Ratio3.5
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)48.89%
Min EPS beat(2)21.06%
Max EPS beat(2)76.73%
EPS beat(4)4
Avg EPS beat(4)115.49%
Min EPS beat(4)21.06%
Max EPS beat(4)281%
EPS beat(8)8
Avg EPS beat(8)165.25%
EPS beat(12)11
Avg EPS beat(12)131.25%
EPS beat(16)13
Avg EPS beat(16)141.33%
Revenue beat(2)1
Avg Revenue beat(2)2.9%
Min Revenue beat(2)-2.47%
Max Revenue beat(2)8.26%
Revenue beat(4)3
Avg Revenue beat(4)4.88%
Min Revenue beat(4)-2.47%
Max Revenue beat(4)8.26%
Revenue beat(8)6
Avg Revenue beat(8)5.53%
Revenue beat(12)10
Avg Revenue beat(12)8.52%
Revenue beat(16)11
Avg Revenue beat(16)5.25%
PT rev (1m)-1.99%
PT rev (3m)-25.2%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-68.23%
EPS NY rev (1m)-4.04%
EPS NY rev (3m)-9.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-45.94%
Revenue NY rev (1m)-2.15%
Revenue NY rev (3m)-4.98%
Valuation
Industry RankSector Rank
PE 10.52
Fwd PE 8.22
P/S 1.04
P/FCF 5.7
P/OCF 5.37
P/B 2.24
P/tB N/A
EV/EBITDA 8.48
EPS(TTM)0.64
EY9.51%
EPS(NY)0.82
Fwd EY12.16%
FCF(TTM)1.18
FCFY17.54%
OCF(TTM)1.25
OCFY18.62%
SpS6.46
BVpS3.01
TBVpS-0.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.52%
ROE -32.56%
ROCE 9.05%
ROIC 7.01%
ROICexc 9.74%
ROICexgc 27.47%
OM 10.95%
PM (TTM) N/A
GM 30.91%
FCFM 18.26%
ROA(3y)-1.11%
ROA(5y)2%
ROE(3y)-11.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-19.68%
ROICexc growth 5YN/A
OM growth 3Y7.58%
OM growth 5YN/A
PM growth 3Y-7.12%
PM growth 5YN/A
GM growth 3Y4.29%
GM growth 5Y45.89%
F-Score4
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF 3.77
Debt/EBITDA 4.02
Cap/Depr 20.53%
Cap/Sales 1.12%
Interest Coverage 2.87
Cash Conversion 118.14%
Profit Quality N/A
Current Ratio 2.41
Quick Ratio 1.88
Altman-Z 1.6
F-Score4
WACC10.23%
ROIC/WACC0.69
Cap/Depr(3y)18.2%
Cap/Depr(5y)13.11%
Cap/Sales(3y)0.71%
Cap/Sales(5y)0.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.56%
EPS 3Y5.44%
EPS 5YN/A
EPS Q2Q%-17.07%
EPS Next Y-45.08%
EPS Next 2Y-15.07%
EPS Next 3Y-5.26%
EPS Next 5Y-0.23%
Revenue 1Y (TTM)-40%
Revenue growth 3Y21.79%
Revenue growth 5Y40.22%
Sales Q2Q%-33.97%
Revenue Next Year-41.25%
Revenue Next 2Y-14.38%
Revenue Next 3Y-6.34%
Revenue Next 5Y-1.89%
EBIT growth 1Y-43.77%
EBIT growth 3Y31.02%
EBIT growth 5YN/A
EBIT Next Year-16.73%
EBIT Next 3Y6.94%
EBIT Next 5Y6.95%
FCF growth 1Y393.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y456.46%
OCF growth 3YN/A
OCF growth 5YN/A